Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |